AcelRx Pharmaceuticals
1 known investors
Find your way into AcelRx Pharmaceuticals
Sign up to see every warm intro you have to AcelRx Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AcelRx Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AcelRx develops medical pain-management products, including a sublingual sufentanil delivery device for use in hospital settings as an alternative to IV patient-controlled analgesia. The company focuses on pharmaceutical and drug-delivery technology for acute pain management.
Investors · 1
Frequently asked questions
- What does AcelRx Pharmaceuticals do?
- AcelRx develops medical pain-management products, including a sublingual sufentanil delivery device for use in hospital settings as an alternative to IV patient-controlled analgesia. The company focuses on pharmaceutical and drug-delivery technology for acute pain management.
- Who are AcelRx Pharmaceuticals's investors?
- AcelRx Pharmaceuticals's investors include Hercules Capital, Inc..
